NCT06539273View on ClinicalTrials.gov

Exosome Treatment in Androgenetic Alopecia

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

May 5, 2024

Conditions
Androgenetic AlopeciaExosomes
Interventions
DRUG

Exosome Complex, RNA

A total of 3 mL of exosomes (2 mL to the frontal and 1 mL to the vertex region) was injected using napage technique (10¹⁰ extracellular vesicles in 1 mL)

Trial Locations (1)

34752

Yeditepe University Kozyatagi Hospital, Istanbul

All Listed Sponsors
lead

Yeditepe University Hospital

OTHER

NCT06539273 - Exosome Treatment in Androgenetic Alopecia | Biotech Hunter | Biotech Hunter